Company intelligence / Profile preview

Yozma Global Genomic Fund

Israel

Ownership: Private
Development stage: Other

Overview

Yozma Group is a venture capital firm founded in 1993 as an Israeli government program to foster the country's high-tech industry. It invests in high-growth companies across Communications, IT, and Life Sciences, and has successfully exited many portfolio companies through IPOs and M&A. Yozma continues to operate through various funds, with a new Yozma 2.0 program launched by the Israel Innovation Authority in 2024.

Industry: Investors

Partnerships

OrbiMedVertex VenturesRedwood Venture PartnersDraper Fisher JurvetsonMorgan StanleySequoia CapitalIntel Venture

Beyond the preview

Go deeper on Yozma Global Genomic Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yozma Global Genomic Fund.

Explore the full profile